...gain of 518%; gene editing company CRISPR Therapeutics AG (NASDAQ:CRSP), at 425%; bispecific mAb company IGM Biosciences Inc....

...editing play Beam Therapeutics Inc. (NASDAQ:BEAM), went public earlier in 2020, while oncology antibody company IGM Biosciences Inc....

...A different tack on antibodies BeiGene Ltd. (NASDAQ:BGNE; HKEX:6160) partnered with Atreca Inc. (NASDAQ:BCEL) and IGM Biosciences Inc....
...crisis can be found at https://www.biocentury.com/coronavirus . Elizabeth S. Eaton, Staff Writer National Institutes of Health BeiGene Ltd. Atreca Inc. IGM Biosciences Inc. Johnson...

...Ramesh Baliga as CSO, a newly created position. Baliga was VP of discovery biology at IGM Biosciences Inc....

...a positive control antibody, while producing comparable lysis of CD19-positive lymphoma cells (No. 4070) . IGM Biosciences Inc....

...09/18/19 $58.0 $168.5 $186.4 11% Shanghai Henlius Biotech Inc. (HKEX:2696) 09/18/19 $409.9 $3,419.4 $3,341.7 -2% IGM Biosciences Inc....

...a market cap of about $211 million. Underwriters are Cowen, Cantor Fitzgerald and William Blair. IGM Biosciences Inc....

...First-day pop for IGM on NASDAQ Oncology antibody company IGM Biosciences Inc. (NASDAQ:IGMS) gained $8.30 (52%) to $24.30...
...Finance. Versantis’ VS-01, a multi-organ supporting therapy for liver disease, is in a first-in-human trial. BC Staff IGM Biosciences Inc. Acadia...

...and Wedbush PacGrow are underwriters (see "SpringWorks Raises $125M Series B" ). Oncology antibody play IGM Biosciences Inc....

...Watch" ). 10x Genomics, IGM file for NASDAQ listings 10x Genomics Inc. (Pleasanton, Calif.) and IGM Biosciences Inc....
...Piper Jaffray, Stifel and Guggenheim. Elizabeth S. Eaton, Staff Writer and Val Kennedy, Associate Editor 10x Genomics Inc. IGM Biosciences Inc. Juvenescence...